SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow ... access to advanced DNA and multi-omic ...
Attend the virtual, two-day IVD conference where international technical experts and scientists will address key aspects of IVD immunoassay (CLIA, immunoturbidimetry, qualitative and quantitative ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Food and Drug Administration (FDA) approval of its in vitro diagnostic (IVD) TruSight™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback